Antares price target raised to $4.00 from $3.50 at Ladenburg Ladenburg raised its price target for Antares following FDA approval of Anturol. The firm reiterates a Buy rating on the stock.
News For AIS From The Last 14 Days
Check below for free stories on AIS the last two weeks.